Biotechnology Amgen/AstraZeneca’s Asthma Drug Tezspire Vs. Sanofi/Regeneron’s Blockbuster Dupixent – Analyst Gives His Pick – AstraZeneca (NASDAQ:AZN), Amgen (NASDAQ:AMGN) Read more
Biotechnology AstraZeneca’s Imfinzi/Chemo Combo Doubles Overall Survival In Biliary Tract Cancer Patients At 3 Years, Data Shows – AstraZeneca (NASDAQ:AZN) Read more
Stockmarkets AstraZeneca CEO could earn 19 million pounds as pay measure clears opposition Reuters via biedexmarkets.com Read more
Opinion Biotech Innovations Paving the Way in Breast Cancer Fight – AstraZeneca (NASDAQ:AZN), Gilead Sciences (NASDAQ:GILD) Read more
Stockmarkets AstraZeneca announces dividend hike ahead of CEO pay vote Reuters via biedexmarkets.com Read more
Biotechnology AstraZeneca/Daiichi’s Flagship Drug Enhertu Secures Accelerated FDA Approval For Pretreated Cancer Patients With Solid Tumor – AstraZeneca (NASDAQ:AZN) Read more
Biotechnology New Hope for Aggressive Lung Cancer: AstraZeneca’s Imfinzi Shows Promising Results in Phase 3 Trial – AstraZeneca (NASDAQ:AZN) Read more
Biotechnology What’s Going With AstraZeneca Stock Trading Higher Today? – AstraZeneca (NASDAQ:AZN) Read more
Biotechnology EXCLUSIVE: 2024 Witnesses Increase In Biotech Initial Public Offerings – AstraZeneca (NASDAQ:AZN) Read more